APA (7th ed.) Citation

Kosmider, O., Possémé, C., Templé, M., Corneau, A., Carbone, F., Duroyon, E., . . . Terrier, B. (2024). VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. Nature Communications, 15(1), . https://doi.org/10.1038/s41467-024-44811-4

Chicago Style (17th ed.) Citation

Kosmider, Olivier, et al. "VEXAS Syndrome Is Characterized by Inflammasome Activation and Monocyte Dysregulation." Nature Communications 15, no. 1 (2024). https://doi.org/10.1038/s41467-024-44811-4.

MLA (9th ed.) Citation

Kosmider, Olivier, et al. "VEXAS Syndrome Is Characterized by Inflammasome Activation and Monocyte Dysregulation." Nature Communications, vol. 15, no. 1, 2024, https://doi.org/10.1038/s41467-024-44811-4.